CHI's New Event to Support the Evolution of Hybrid Scientists in Biopharma R&D BOSTON , Aug. 20, 2024 /PRNewswire/ -- Biopharmaceutical research is undergoing the most significant change in decades as new machine learning and AI tools and models enable scientists to improve the speed and quality of the R&D pipeline. On January 13-16, 2025, leading scientists from the biopharmaceutical research community will gather for the inaugural BioLogic Summit in San Diego, CA to explore the transformative power of machine learning and artificial intelligence in biopharmaceutical R&D.
The Summit has been designed to meet the needs of the growing community of hybrid scientists that will empower this new research paradigm: experimentalists now working with AI/ML and computational tools, and data scientists adapting to the complex world of drug discovery and protein science. The event will feature a comprehensive program, including conference tracks , luminary Plenary Keynotes, moderated small-group discussions, and a range of one-day training seminars to meet the needs of participants at every level. "Through our PEGS and PepTalk events, we have seen an increasing demand for programming to support the introduction of these new tools in early discovery and biopharmaceutical development.
The BioLogic Summit allows us to build on these conferences and offer a new meeting entirely focused on the use of these tools in bringing biologic drugs to patients," says Christina Lingham , Executive Dire.